Retinal Vein Occlusion

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)

Terminated
  • Wet Age-related Macular Degeneration
  • +2 more
  • Phoenix, Arizona
  • +10 more
Nov 1, 2022

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Macular Edema
  • Retinal Vein Occlusion
  • Phoenix, Arizona
  • +140 more
Jul 20, 2022

Retinal Vein Occlusion, Macula Edema Trial in United States (TLC399 (ProDex))

Completed
  • Retinal Vein Occlusion
  • Macula Edema
  • TLC399 (ProDex)
  • Phoenix, Arizona
  • +19 more
Nov 24, 2021

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, Lucentis or Avastin)

Terminated
  • Macular Edema
  • Retinal Vein Occlusion
  • suprachoroidal CLS-TA
  • +2 more
  • Phoenix, Arizona
  • +91 more
Apr 22, 2021

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, IVT aflibercept)

Terminated
  • Macular Edema
  • Retinal Vein Occlusion
  • suprachoroidal CLS-TA
  • +2 more
  • Peoria, Arizona
  • +109 more
Mar 18, 2021

Macular Edema, Retinal Vein Occlusion Trial in United States (4 mg CLS-TA, Sham, IVT aflibercept)

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • 4 mg CLS-TA
  • +2 more
  • Phoenix, Arizona
  • +13 more
Jan 18, 2021

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (AGN208397 intravitreal injection, dexamethasone intravitreal implant)

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • AGN208397 intravitreal injection
  • dexamethasone intravitreal implant
  • Phoenix, Arizona
  • +4 more
Mar 27, 2014